HANGZHOU, China and LONDON, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, was invited to present at the 2025 LSX World Congress in Boston. The company delivered a keynote presentation entitled “AI-Designed Oral GLP-1RA: First-in-Class Phase IIb Clinical Readouts and Translational Insights”. This marks the first international presentation of MDR-001’s update clinical results, sparking significant interest and discussion among glob ...